Literature DB >> 17692832

An investigation into the lipid-binding properties of alpha-, beta- and gamma-synucleins in human brain and cerebrospinal fluid.

Sultan A Salem1, David Allsop, David M A Mann, Takahiko Tokuda, Omar M A El-Agnaf.   

Abstract

Parkinson's disease (PD) and dementia with Lewy bodies (DLB) are both characterized by the formation and intraneuronal accumulation of fibrillar aggregates of alpha-synuclein (alpha-syn) protein in affected brain regions. alpha-Syn has biochemical properties and a structural motif characteristic of fatty acid binding proteins. Using the fatty acid binding resin Lipidex-1000, we investigated the capture of alpha-, beta-, and gamma-syn proteins as lipid-associated proteins from normal and DLB brain lysates, and from normal human cerebrospinal fluid (CSF). These were eluted from Lipidex-1000 and analyzed by SDS-NuPAGE followed by Western blotting. Using this methodology, we have been able to extract full-length and truncated forms of alpha-syn from brain lysates. We also extracted low levels of beta-syn from DLB brains, but failed to extract any gamma-syn. We were able to capture only full-length monomeric alpha-syn from normal human CSF. Our data confirm the fatty acid binding properties of alpha-syn, and to a lesser extent beta-syn, but suggest that gamma-syn does not share this same characteristic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692832     DOI: 10.1016/j.brainres.2007.07.027

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein.

Authors:  Eitan Israeli; Ronit Sharon
Journal:  J Neurochem       Date:  2008-12-02       Impact factor: 5.372

2.  Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease.

Authors:  Eliezer Masliah; Edward Rockenstein; Michael Mante; Leslie Crews; Brian Spencer; Anthony Adame; Christina Patrick; Margarita Trejo; Kiren Ubhi; Troy T Rohn; Sarah Mueller-Steiner; Peter Seubert; Robin Barbour; Lisa McConlogue; Manuel Buttini; Dora Games; Dale Schenk
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

3.  Lentivirus-mediated downregulation of α-synuclein reduces neuroinflammation and promotes functional recovery in rats with spinal cord injury.

Authors:  Hong Zeng; Nan Liu; Yan-Yan Yang; Hua-Yi Xing; Xiao-Xie Liu; Fang Li; Gao-Yan La; Meng-Jie Huang; Mou-Wang Zhou
Journal:  J Neuroinflammation       Date:  2019-12-30       Impact factor: 8.322

Review 4.  β-Synuclein: An Enigmatic Protein with Diverse Functionality.

Authors:  Junna Hayashi; John A Carver
Journal:  Biomolecules       Date:  2022-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.